StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Myomo, Inc.
NYSE American:MYO
Sector
Location
Market Cap
USD 74.84 M
Share Price
USD 2.08
Avg Daily Volume
564,261
Change (1 day)
-3.70%
Change (1 year)
-25.98%
Change (YTD)
-67.70%
Myomo, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 0.99
Myomo, Inc. Revenue Per Share is USD 0.99 for the Trailing 12 Months (TTM) ending March 31, 2025, a 71.60% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Myomo, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 0.58, a -56.49% change year over year.
-
Myomo, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.33, a -46.53% change year over year.
-
Myomo, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.49, a 16.34% change year over year.
-
Myomo, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.14, a -37.47% change year over year.
Competitors
PROCEPT BioRobotics Corporation
USD 58.18
PRCT
+1.61
2.85%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Cencora, Inc.
USD 291.17
COR
-4.16
-1.41%
Edwards Lifesciences Corporation
USD 77.02
EW
-0.16
-0.21%
GE HealthCare Technologies Inc.
USD 76.12
GEHC
+0.17
0.22%
DexCom, Inc.
USD 83.58
DXCM
0.00%
IQVIA Holdings Inc.
USD 164.65
IQV
+2.04
1.26%
Laboratory Corporation of America Holdings
USD 260.00
LH
-4.26
-1.61%
Natera, Inc.
USD 161.57
NTRA
+0.85
0.53%
Baxter International Inc.
USD 31.13
BAX
-0.10
-0.32%
Hologic, Inc.
USD 65.30
HOLX
-0.03
-0.05%
Somnigroup International Inc
USD 71.73
SGI
+2.04
2.93%
Torrent Pharmaceuticals Limited
USD 38.99
TORNTPHARM.NS
-0.12
-0.32%
Fisher & Paykel Healthcare Corporation Limited
USD 22.14
FPH.NZ
-0.68
-2.99%
ICON Public Limited Company
USD 150.82
ICLR
+1.94
1.30%
Zydus Lifesciences Limited
USD 11.62
ZYDUSLIFE.NS
-0.01
-0.04%
Ascendis Pharma A/S
USD 173.10
ASND
+1.10
0.64%
Exact Sciences Corporation
USD 53.86
EXAS
-0.74
-1.35%
Penumbra, Inc.
USD 249.74
PEN
-0.94
-0.38%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
PROCEPT BioRobotics Corporation
USD 58.18
PRCT
+1.61
2.85%
Boston Scientific Corporation
USD 103.63
BSX
-1.15
-1.10%
Siemens Healthineers AG
USD 55.95
SHL.DE
+0.55
1.00%
Cencora, Inc.
USD 291.17
COR
-4.16
-1.41%
Edwards Lifesciences Corporation
USD 77.02
EW
-0.16
-0.21%
GE HealthCare Technologies Inc.
USD 76.12
GEHC
+0.17
0.22%
DexCom, Inc.
USD 83.58
DXCM
0.00%
IQVIA Holdings Inc.
USD 164.65
IQV
+2.04
1.26%
Laboratory Corporation of America Holdings
USD 260.00
LH
-4.26
-1.61%
Natera, Inc.
USD 161.57
NTRA
+0.85
0.53%
Baxter International Inc.
USD 31.13
BAX
-0.10
-0.32%
Hologic, Inc.
USD 65.30
HOLX
-0.03
-0.05%
Somnigroup International Inc
USD 71.73
SGI
+2.04
2.93%
Torrent Pharmaceuticals Limited
USD 38.99
TORNTPHARM.NS
-0.12
-0.32%
Fisher & Paykel Healthcare Corporation Limited
USD 22.14
FPH.NZ
-0.68
-2.99%
ICON Public Limited Company
USD 150.82
ICLR
+1.94
1.30%
Zydus Lifesciences Limited
USD 11.62
ZYDUSLIFE.NS
-0.01
-0.04%
Ascendis Pharma A/S
USD 173.10
ASND
+1.10
0.64%
Exact Sciences Corporation
USD 53.86
EXAS
-0.74
-1.35%
Penumbra, Inc.
USD 249.74
PEN
-0.94
-0.38%